GlassScriptPhysician profile
Michael Aziz
NPI 1619067998
$17,034.97
in general payments reported to CMS, 2019-2025
38 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $549 · 2021: $810 · 2022: $1,172 · 2023: $1,986 · 2024: $1,471 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $8,100 · Food and Beverage: $5,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $8,100.00 |
| Food and Beverage | $5,371.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $8,124.26 | 2024-2025 | Venclose Maven Catheter |
| Gilead Sciences, INC. | $2,341.14 | 2019-2025 | Descovy, Biktarvy |
| Viiv Healthcare Company | $2,064.56 | 2019-2025 | Apretude, Dovato, Cabenuva |
| Novo Nordisk INC | $652.58 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $357.49 | 2020-2025 | Delstrigo, Pifeltro, Dificid |
| Endo Pharmaceuticals INC. | $290.25 | 2019-2024 | Xiaflex, Aveed, Edex |
| Corium, LLC | $290.05 | 2023-2025 | Azstarys |
| Angiodynamics, INC. | $284.37 | 2023-2024 | Venacure 1470 Pro |
| Idorsia Pharmaceuticals US INC | $256.47 | 2022-2024 | Quviviq |
| Boston Scientific Corporation | $256.07 | 2022-2024 | Wavewriter Alpha Prime 16, Varithena Administration Pack |
| Astrazeneca Pharmaceuticals LP | $255.22 | 2019-2024 | Airsupra, Farxiga |
| Lilly USA, LLC | $242.71 | 2020-2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $221.18 | 2020-2021 | |
| Antares Pharma, INC. | $162.28 | 2025 | Xyosted |
| Pfizer INC. | $128.11 | 2023 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Abbvie INC. | $122.91 | 2021-2025 | Linzess, Viberzi |
| Biocompatibles, INC. | $120.93 | 2019 | |
| Emd Serono, INC. | $102.97 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $92.98 | 2022 | |
| Philips North America LLC | $53.94 | 2024 | (Ck7) Extended Holter |
| Glaxosmithkline, LLC. | $48.16 | 2023-2024 | Arexvy, Shingrix |
| Bardy Diagnostics, INC. | $45.00 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.10 | 2022 | |
| Paratek Pharmaceuticals, INC. | $42.83 | 2021 | |
| Genzyme Corporation | $37.81 | 2025 | |
| Allergan, INC. | $33.50 | 2020 | |
| Genentech USA, INC. | $30.58 | 2022 | |
| Adlon Therapeutics L.P. | $28.86 | 2019-2021 | |
| Axsome Therapeutics, INC. | $28.51 | 2025 | Auvelity |
| Amgen INC. | $25.93 | 2023 | Repatha |
| Medline Industries LP | $25.59 | 2024 | |
| Linus Health, INC. | $20.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.15 | 2022 | |
| Eisai INC. | $17.24 | 2021 | |
| Hologic Sales and Service, LLC | $16.52 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $15.13 | 2022 | |
| Celltrion, INC. | $10.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Aziz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.